nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN2D—prostate gland—urinary bladder cancer	0.000994	0.203	CbGeAlD
Acamprosate—GRM5—female reproductive system—urinary bladder cancer	0.000766	0.156	CbGeAlD
Acamprosate—SLC36A1—prostate gland—urinary bladder cancer	0.000734	0.15	CbGeAlD
Acamprosate—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000694	0.000697	CcSEcCtD
Acamprosate—Weight increased—Doxorubicin—urinary bladder cancer	0.000692	0.000695	CcSEcCtD
Acamprosate—Epistaxis—Epirubicin—urinary bladder cancer	0.000691	0.000694	CcSEcCtD
Acamprosate—Pruritus—Gemcitabine—urinary bladder cancer	0.00069	0.000694	CcSEcCtD
Acamprosate—Nausea—Thiotepa—urinary bladder cancer	0.000689	0.000692	CcSEcCtD
Acamprosate—Weight decreased—Doxorubicin—urinary bladder cancer	0.000687	0.000691	CcSEcCtD
Acamprosate—Feeling abnormal—Etoposide—urinary bladder cancer	0.000687	0.00069	CcSEcCtD
Acamprosate—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000685	0.000689	CcSEcCtD
Acamprosate—Pneumonia—Doxorubicin—urinary bladder cancer	0.000681	0.000685	CcSEcCtD
Acamprosate—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000681	0.000685	CcSEcCtD
Acamprosate—Pruritus—Fluorouracil—urinary bladder cancer	0.000679	0.000682	CcSEcCtD
Acamprosate—Visual impairment—Methotrexate—urinary bladder cancer	0.000677	0.00068	CcSEcCtD
Acamprosate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00067	0.000673	CcSEcCtD
Acamprosate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000668	0.000671	CcSEcCtD
Acamprosate—Urticaria—Etoposide—urinary bladder cancer	0.000662	0.000665	CcSEcCtD
Acamprosate—Haemoglobin—Epirubicin—urinary bladder cancer	0.000661	0.000664	CcSEcCtD
Acamprosate—Stomatitis—Doxorubicin—urinary bladder cancer	0.00066	0.000664	CcSEcCtD
Acamprosate—Rhinitis—Epirubicin—urinary bladder cancer	0.000659	0.000662	CcSEcCtD
Acamprosate—Abdominal pain—Etoposide—urinary bladder cancer	0.000659	0.000662	CcSEcCtD
Acamprosate—Body temperature increased—Etoposide—urinary bladder cancer	0.000659	0.000662	CcSEcCtD
Acamprosate—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000659	0.000662	CcSEcCtD
Acamprosate—Haemorrhage—Epirubicin—urinary bladder cancer	0.000657	0.000661	CcSEcCtD
Acamprosate—Hepatitis—Epirubicin—urinary bladder cancer	0.000657	0.000661	CcSEcCtD
Acamprosate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000656	0.00066	CcSEcCtD
Acamprosate—Tinnitus—Methotrexate—urinary bladder cancer	0.000655	0.000658	CcSEcCtD
Acamprosate—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000654	0.000657	CcSEcCtD
Acamprosate—Asthenia—Cisplatin—urinary bladder cancer	0.000652	0.000656	CcSEcCtD
Acamprosate—Pharyngitis—Epirubicin—urinary bladder cancer	0.000652	0.000656	CcSEcCtD
Acamprosate—Sweating—Doxorubicin—urinary bladder cancer	0.00065	0.000653	CcSEcCtD
Acamprosate—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000648	0.000651	CcSEcCtD
Acamprosate—Haematuria—Doxorubicin—urinary bladder cancer	0.000646	0.000649	CcSEcCtD
Acamprosate—Epistaxis—Doxorubicin—urinary bladder cancer	0.000639	0.000642	CcSEcCtD
Acamprosate—Immune system disorder—Methotrexate—urinary bladder cancer	0.000634	0.000638	CcSEcCtD
Acamprosate—Dizziness—Fluorouracil—urinary bladder cancer	0.000634	0.000637	CcSEcCtD
Acamprosate—Visual impairment—Epirubicin—urinary bladder cancer	0.000633	0.000637	CcSEcCtD
Acamprosate—Chills—Methotrexate—urinary bladder cancer	0.00063	0.000633	CcSEcCtD
Acamprosate—Diarrhoea—Cisplatin—urinary bladder cancer	0.000622	0.000625	CcSEcCtD
Acamprosate—Alopecia—Methotrexate—urinary bladder cancer	0.000621	0.000624	CcSEcCtD
Acamprosate—Vomiting—Gemcitabine—urinary bladder cancer	0.00062	0.000623	CcSEcCtD
Acamprosate—Mental disorder—Methotrexate—urinary bladder cancer	0.000615	0.000618	CcSEcCtD
Acamprosate—Rash—Gemcitabine—urinary bladder cancer	0.000615	0.000618	CcSEcCtD
Acamprosate—Dermatitis—Gemcitabine—urinary bladder cancer	0.000615	0.000618	CcSEcCtD
Acamprosate—Hypersensitivity—Etoposide—urinary bladder cancer	0.000614	0.000617	CcSEcCtD
Acamprosate—Tinnitus—Epirubicin—urinary bladder cancer	0.000613	0.000616	CcSEcCtD
Acamprosate—Malnutrition—Methotrexate—urinary bladder cancer	0.000611	0.000614	CcSEcCtD
Acamprosate—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000611	0.000614	CcSEcCtD
Acamprosate—Headache—Gemcitabine—urinary bladder cancer	0.000611	0.000614	CcSEcCtD
Acamprosate—Vomiting—Fluorouracil—urinary bladder cancer	0.00061	0.000613	CcSEcCtD
Acamprosate—Rhinitis—Doxorubicin—urinary bladder cancer	0.00061	0.000613	CcSEcCtD
Acamprosate—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000608	0.000611	CcSEcCtD
Acamprosate—Hepatitis—Doxorubicin—urinary bladder cancer	0.000608	0.000611	CcSEcCtD
Acamprosate—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000605	0.000608	CcSEcCtD
Acamprosate—Rash—Fluorouracil—urinary bladder cancer	0.000605	0.000608	CcSEcCtD
Acamprosate—Dermatitis—Fluorouracil—urinary bladder cancer	0.000604	0.000607	CcSEcCtD
Acamprosate—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000604	0.000607	CcSEcCtD
Acamprosate—Headache—Fluorouracil—urinary bladder cancer	0.000601	0.000604	CcSEcCtD
Acamprosate—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000599	0.000602	CcSEcCtD
Acamprosate—Dysgeusia—Methotrexate—urinary bladder cancer	0.000599	0.000602	CcSEcCtD
Acamprosate—Asthenia—Etoposide—urinary bladder cancer	0.000598	0.000601	CcSEcCtD
Acamprosate—Immune system disorder—Epirubicin—urinary bladder cancer	0.000594	0.000597	CcSEcCtD
Acamprosate—Back pain—Methotrexate—urinary bladder cancer	0.000591	0.000594	CcSEcCtD
Acamprosate—Chills—Epirubicin—urinary bladder cancer	0.00059	0.000593	CcSEcCtD
Acamprosate—Pruritus—Etoposide—urinary bladder cancer	0.000589	0.000592	CcSEcCtD
Acamprosate—Visual impairment—Doxorubicin—urinary bladder cancer	0.000586	0.000589	CcSEcCtD
Acamprosate—Alopecia—Epirubicin—urinary bladder cancer	0.000581	0.000584	CcSEcCtD
Acamprosate—Nausea—Gemcitabine—urinary bladder cancer	0.00058	0.000582	CcSEcCtD
Acamprosate—Vomiting—Cisplatin—urinary bladder cancer	0.000578	0.000581	CcSEcCtD
Acamprosate—Mental disorder—Epirubicin—urinary bladder cancer	0.000576	0.000579	CcSEcCtD
Acamprosate—Rash—Cisplatin—urinary bladder cancer	0.000573	0.000576	CcSEcCtD
Acamprosate—Dermatitis—Cisplatin—urinary bladder cancer	0.000573	0.000576	CcSEcCtD
Acamprosate—Malnutrition—Epirubicin—urinary bladder cancer	0.000572	0.000575	CcSEcCtD
Acamprosate—Diarrhoea—Etoposide—urinary bladder cancer	0.00057	0.000573	CcSEcCtD
Acamprosate—Nausea—Fluorouracil—urinary bladder cancer	0.00057	0.000573	CcSEcCtD
Acamprosate—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000567	0.00057	CcSEcCtD
Acamprosate—Tinnitus—Doxorubicin—urinary bladder cancer	0.000567	0.00057	CcSEcCtD
Acamprosate—Anaemia—Methotrexate—urinary bladder cancer	0.000565	0.000568	CcSEcCtD
Acamprosate—Flatulence—Epirubicin—urinary bladder cancer	0.000564	0.000567	CcSEcCtD
Acamprosate—Tension—Epirubicin—urinary bladder cancer	0.000562	0.000564	CcSEcCtD
Acamprosate—Dysgeusia—Epirubicin—urinary bladder cancer	0.00056	0.000563	CcSEcCtD
Acamprosate—Nervousness—Epirubicin—urinary bladder cancer	0.000556	0.000559	CcSEcCtD
Acamprosate—Back pain—Epirubicin—urinary bladder cancer	0.000553	0.000556	CcSEcCtD
Acamprosate—Malaise—Methotrexate—urinary bladder cancer	0.000551	0.000554	CcSEcCtD
Acamprosate—Dizziness—Etoposide—urinary bladder cancer	0.000551	0.000554	CcSEcCtD
Acamprosate—Muscle spasms—Epirubicin—urinary bladder cancer	0.00055	0.000553	CcSEcCtD
Acamprosate—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000549	0.000552	CcSEcCtD
Acamprosate—Vertigo—Methotrexate—urinary bladder cancer	0.000549	0.000552	CcSEcCtD
Acamprosate—Leukopenia—Methotrexate—urinary bladder cancer	0.000547	0.00055	CcSEcCtD
Acamprosate—Chills—Doxorubicin—urinary bladder cancer	0.000546	0.000548	CcSEcCtD
Acamprosate—Nausea—Cisplatin—urinary bladder cancer	0.00054	0.000543	CcSEcCtD
Acamprosate—Alopecia—Doxorubicin—urinary bladder cancer	0.000537	0.00054	CcSEcCtD
Acamprosate—Cough—Methotrexate—urinary bladder cancer	0.000534	0.000536	CcSEcCtD
Acamprosate—Mental disorder—Doxorubicin—urinary bladder cancer	0.000533	0.000535	CcSEcCtD
Acamprosate—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000531	0.000534	CcSEcCtD
Acamprosate—Convulsion—Methotrexate—urinary bladder cancer	0.00053	0.000532	CcSEcCtD
Acamprosate—Vomiting—Etoposide—urinary bladder cancer	0.00053	0.000532	CcSEcCtD
Acamprosate—Malnutrition—Doxorubicin—urinary bladder cancer	0.000529	0.000532	CcSEcCtD
Acamprosate—Anaemia—Epirubicin—urinary bladder cancer	0.000529	0.000531	CcSEcCtD
Acamprosate—Agitation—Epirubicin—urinary bladder cancer	0.000526	0.000528	CcSEcCtD
Acamprosate—Rash—Etoposide—urinary bladder cancer	0.000525	0.000528	CcSEcCtD
Acamprosate—Dermatitis—Etoposide—urinary bladder cancer	0.000525	0.000527	CcSEcCtD
Acamprosate—Headache—Etoposide—urinary bladder cancer	0.000522	0.000524	CcSEcCtD
Acamprosate—Flatulence—Doxorubicin—urinary bladder cancer	0.000522	0.000524	CcSEcCtD
Acamprosate—Chest pain—Methotrexate—urinary bladder cancer	0.000521	0.000523	CcSEcCtD
Acamprosate—Myalgia—Methotrexate—urinary bladder cancer	0.000521	0.000523	CcSEcCtD
Acamprosate—Arthralgia—Methotrexate—urinary bladder cancer	0.000521	0.000523	CcSEcCtD
Acamprosate—Tension—Doxorubicin—urinary bladder cancer	0.00052	0.000522	CcSEcCtD
Acamprosate—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000518	0.000521	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000517	0.00052	CcSEcCtD
Acamprosate—Malaise—Epirubicin—urinary bladder cancer	0.000516	0.000519	CcSEcCtD
Acamprosate—Discomfort—Methotrexate—urinary bladder cancer	0.000514	0.000517	CcSEcCtD
Acamprosate—Nervousness—Doxorubicin—urinary bladder cancer	0.000514	0.000517	CcSEcCtD
Acamprosate—Vertigo—Epirubicin—urinary bladder cancer	0.000514	0.000517	CcSEcCtD
Acamprosate—Syncope—Epirubicin—urinary bladder cancer	0.000513	0.000516	CcSEcCtD
Acamprosate—Leukopenia—Epirubicin—urinary bladder cancer	0.000512	0.000515	CcSEcCtD
Acamprosate—Back pain—Doxorubicin—urinary bladder cancer	0.000512	0.000515	CcSEcCtD
Acamprosate—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000509	0.000512	CcSEcCtD
Acamprosate—Palpitations—Epirubicin—urinary bladder cancer	0.000506	0.000508	CcSEcCtD
Acamprosate—Confusional state—Methotrexate—urinary bladder cancer	0.000503	0.000506	CcSEcCtD
Acamprosate—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000503	0.000505	CcSEcCtD
Acamprosate—SLC36A1—renal system—urinary bladder cancer	0.0005	0.102	CbGeAlD
Acamprosate—Cough—Epirubicin—urinary bladder cancer	0.000499	0.000502	CcSEcCtD
Acamprosate—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000499	0.000501	CcSEcCtD
Acamprosate—Convulsion—Epirubicin—urinary bladder cancer	0.000496	0.000498	CcSEcCtD
Acamprosate—Infection—Methotrexate—urinary bladder cancer	0.000496	0.000498	CcSEcCtD
Acamprosate—Nausea—Etoposide—urinary bladder cancer	0.000495	0.000497	CcSEcCtD
Acamprosate—Hypertension—Epirubicin—urinary bladder cancer	0.000494	0.000496	CcSEcCtD
Acamprosate—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000491	0.000494	CcSEcCtD
Acamprosate—Anaemia—Doxorubicin—urinary bladder cancer	0.000489	0.000492	CcSEcCtD
Acamprosate—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000489	0.000491	CcSEcCtD
Acamprosate—Chest pain—Epirubicin—urinary bladder cancer	0.000487	0.00049	CcSEcCtD
Acamprosate—Arthralgia—Epirubicin—urinary bladder cancer	0.000487	0.00049	CcSEcCtD
Acamprosate—Myalgia—Epirubicin—urinary bladder cancer	0.000487	0.00049	CcSEcCtD
Acamprosate—Agitation—Doxorubicin—urinary bladder cancer	0.000487	0.000489	CcSEcCtD
Acamprosate—Anxiety—Epirubicin—urinary bladder cancer	0.000485	0.000488	CcSEcCtD
Acamprosate—Skin disorder—Methotrexate—urinary bladder cancer	0.000485	0.000487	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000484	0.000486	CcSEcCtD
Acamprosate—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000482	0.000485	CcSEcCtD
Acamprosate—Discomfort—Epirubicin—urinary bladder cancer	0.000481	0.000484	CcSEcCtD
Acamprosate—Malaise—Doxorubicin—urinary bladder cancer	0.000477	0.00048	CcSEcCtD
Acamprosate—Dry mouth—Epirubicin—urinary bladder cancer	0.000476	0.000479	CcSEcCtD
Acamprosate—Vertigo—Doxorubicin—urinary bladder cancer	0.000476	0.000478	CcSEcCtD
Acamprosate—Anorexia—Methotrexate—urinary bladder cancer	0.000476	0.000478	CcSEcCtD
Acamprosate—Syncope—Doxorubicin—urinary bladder cancer	0.000475	0.000477	CcSEcCtD
Acamprosate—Leukopenia—Doxorubicin—urinary bladder cancer	0.000474	0.000476	CcSEcCtD
Acamprosate—Confusional state—Epirubicin—urinary bladder cancer	0.000471	0.000473	CcSEcCtD
Acamprosate—Palpitations—Doxorubicin—urinary bladder cancer	0.000468	0.00047	CcSEcCtD
Acamprosate—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000467	0.000469	CcSEcCtD
Acamprosate—Hypotension—Methotrexate—urinary bladder cancer	0.000466	0.000469	CcSEcCtD
Acamprosate—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000465	0.000468	CcSEcCtD
Acamprosate—Infection—Epirubicin—urinary bladder cancer	0.000464	0.000466	CcSEcCtD
Acamprosate—Cough—Doxorubicin—urinary bladder cancer	0.000462	0.000464	CcSEcCtD
Acamprosate—Shock—Epirubicin—urinary bladder cancer	0.000459	0.000462	CcSEcCtD
Acamprosate—Convulsion—Doxorubicin—urinary bladder cancer	0.000459	0.000461	CcSEcCtD
Acamprosate—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000457	0.00046	CcSEcCtD
Acamprosate—Hypertension—Doxorubicin—urinary bladder cancer	0.000457	0.000459	CcSEcCtD
Acamprosate—Tachycardia—Epirubicin—urinary bladder cancer	0.000456	0.000458	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000455	0.000457	CcSEcCtD
Acamprosate—Skin disorder—Epirubicin—urinary bladder cancer	0.000454	0.000456	CcSEcCtD
Acamprosate—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000451	0.000454	CcSEcCtD
Acamprosate—Insomnia—Methotrexate—urinary bladder cancer	0.000451	0.000454	CcSEcCtD
Acamprosate—Arthralgia—Doxorubicin—urinary bladder cancer	0.000451	0.000453	CcSEcCtD
Acamprosate—Chest pain—Doxorubicin—urinary bladder cancer	0.000451	0.000453	CcSEcCtD
Acamprosate—Myalgia—Doxorubicin—urinary bladder cancer	0.000451	0.000453	CcSEcCtD
Acamprosate—Anxiety—Doxorubicin—urinary bladder cancer	0.000449	0.000451	CcSEcCtD
Acamprosate—Paraesthesia—Methotrexate—urinary bladder cancer	0.000448	0.00045	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000448	0.00045	CcSEcCtD
Acamprosate—Discomfort—Doxorubicin—urinary bladder cancer	0.000445	0.000448	CcSEcCtD
Acamprosate—Anorexia—Epirubicin—urinary bladder cancer	0.000445	0.000447	CcSEcCtD
Acamprosate—Dyspnoea—Methotrexate—urinary bladder cancer	0.000445	0.000447	CcSEcCtD
Acamprosate—Somnolence—Methotrexate—urinary bladder cancer	0.000444	0.000446	CcSEcCtD
Acamprosate—Dry mouth—Doxorubicin—urinary bladder cancer	0.000441	0.000443	CcSEcCtD
Acamprosate—Dyspepsia—Methotrexate—urinary bladder cancer	0.000439	0.000441	CcSEcCtD
Acamprosate—Hypotension—Epirubicin—urinary bladder cancer	0.000436	0.000439	CcSEcCtD
Acamprosate—Confusional state—Doxorubicin—urinary bladder cancer	0.000436	0.000438	CcSEcCtD
Acamprosate—Decreased appetite—Methotrexate—urinary bladder cancer	0.000434	0.000436	CcSEcCtD
Acamprosate—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000432	0.000434	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000431	0.000433	CcSEcCtD
Acamprosate—Infection—Doxorubicin—urinary bladder cancer	0.000429	0.000431	CcSEcCtD
Acamprosate—Pain—Methotrexate—urinary bladder cancer	0.000427	0.000429	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000425	0.000428	CcSEcCtD
Acamprosate—Shock—Doxorubicin—urinary bladder cancer	0.000425	0.000427	CcSEcCtD
Acamprosate—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000423	0.000425	CcSEcCtD
Acamprosate—Insomnia—Epirubicin—urinary bladder cancer	0.000422	0.000424	CcSEcCtD
Acamprosate—Tachycardia—Doxorubicin—urinary bladder cancer	0.000422	0.000424	CcSEcCtD
Acamprosate—Skin disorder—Doxorubicin—urinary bladder cancer	0.00042	0.000422	CcSEcCtD
Acamprosate—Paraesthesia—Epirubicin—urinary bladder cancer	0.000419	0.000421	CcSEcCtD
Acamprosate—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000418	0.00042	CcSEcCtD
Acamprosate—Dyspnoea—Epirubicin—urinary bladder cancer	0.000416	0.000418	CcSEcCtD
Acamprosate—Somnolence—Epirubicin—urinary bladder cancer	0.000415	0.000417	CcSEcCtD
Acamprosate—Anorexia—Doxorubicin—urinary bladder cancer	0.000412	0.000414	CcSEcCtD
Acamprosate—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000411	0.000413	CcSEcCtD
Acamprosate—Dyspepsia—Epirubicin—urinary bladder cancer	0.000411	0.000413	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000408	0.00041	CcSEcCtD
Acamprosate—Decreased appetite—Epirubicin—urinary bladder cancer	0.000406	0.000408	CcSEcCtD
Acamprosate—Hypotension—Doxorubicin—urinary bladder cancer	0.000404	0.000406	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000403	0.000405	CcSEcCtD
Acamprosate—SLC36A1—female reproductive system—urinary bladder cancer	0.000401	0.0816	CbGeAlD
Acamprosate—Constipation—Epirubicin—urinary bladder cancer	0.000399	0.000401	CcSEcCtD
Acamprosate—Pain—Epirubicin—urinary bladder cancer	0.000399	0.000401	CcSEcCtD
Acamprosate—Urticaria—Methotrexate—urinary bladder cancer	0.000396	0.000398	CcSEcCtD
Acamprosate—Body temperature increased—Methotrexate—urinary bladder cancer	0.000394	0.000396	CcSEcCtD
Acamprosate—Abdominal pain—Methotrexate—urinary bladder cancer	0.000394	0.000396	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000394	0.000396	CcSEcCtD
Acamprosate—Insomnia—Doxorubicin—urinary bladder cancer	0.000391	0.000393	CcSEcCtD
Acamprosate—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000388	0.00039	CcSEcCtD
Acamprosate—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000385	0.000387	CcSEcCtD
Acamprosate—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000385	0.000387	CcSEcCtD
Acamprosate—Somnolence—Doxorubicin—urinary bladder cancer	0.000384	0.000386	CcSEcCtD
Acamprosate—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000382	0.000384	CcSEcCtD
Acamprosate—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00038	0.000382	CcSEcCtD
Acamprosate—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000376	0.000377	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000373	0.000375	CcSEcCtD
Acamprosate—Urticaria—Epirubicin—urinary bladder cancer	0.000371	0.000373	CcSEcCtD
Acamprosate—Pain—Doxorubicin—urinary bladder cancer	0.00037	0.000371	CcSEcCtD
Acamprosate—Constipation—Doxorubicin—urinary bladder cancer	0.00037	0.000371	CcSEcCtD
Acamprosate—Abdominal pain—Epirubicin—urinary bladder cancer	0.000369	0.000371	CcSEcCtD
Acamprosate—Body temperature increased—Epirubicin—urinary bladder cancer	0.000369	0.000371	CcSEcCtD
Acamprosate—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000368	0.000369	CcSEcCtD
Acamprosate—GRIN2A—vagina—urinary bladder cancer	0.000365	0.0743	CbGeAlD
Acamprosate—SLC36A1—vagina—urinary bladder cancer	0.000362	0.0738	CbGeAlD
Acamprosate—Asthenia—Methotrexate—urinary bladder cancer	0.000358	0.00036	CcSEcCtD
Acamprosate—GABRB3—prostate gland—urinary bladder cancer	0.000357	0.0728	CbGeAlD
Acamprosate—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000356	0.000358	CcSEcCtD
Acamprosate—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000353	0.000355	CcSEcCtD
Acamprosate—Pruritus—Methotrexate—urinary bladder cancer	0.000353	0.000355	CcSEcCtD
Acamprosate—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000344	0.000346	CcSEcCtD
Acamprosate—Urticaria—Doxorubicin—urinary bladder cancer	0.000343	0.000345	CcSEcCtD
Acamprosate—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000342	0.000343	CcSEcCtD
Acamprosate—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000342	0.000343	CcSEcCtD
Acamprosate—Diarrhoea—Methotrexate—urinary bladder cancer	0.000341	0.000343	CcSEcCtD
Acamprosate—Asthenia—Epirubicin—urinary bladder cancer	0.000335	0.000337	CcSEcCtD
Acamprosate—Pruritus—Epirubicin—urinary bladder cancer	0.00033	0.000332	CcSEcCtD
Acamprosate—Dizziness—Methotrexate—urinary bladder cancer	0.00033	0.000332	CcSEcCtD
Acamprosate—Diarrhoea—Epirubicin—urinary bladder cancer	0.00032	0.000321	CcSEcCtD
Acamprosate—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000318	0.00032	CcSEcCtD
Acamprosate—Vomiting—Methotrexate—urinary bladder cancer	0.000317	0.000319	CcSEcCtD
Acamprosate—Rash—Methotrexate—urinary bladder cancer	0.000315	0.000316	CcSEcCtD
Acamprosate—Dermatitis—Methotrexate—urinary bladder cancer	0.000314	0.000316	CcSEcCtD
Acamprosate—Headache—Methotrexate—urinary bladder cancer	0.000313	0.000314	CcSEcCtD
Acamprosate—Asthenia—Doxorubicin—urinary bladder cancer	0.00031	0.000312	CcSEcCtD
Acamprosate—Dizziness—Epirubicin—urinary bladder cancer	0.000309	0.00031	CcSEcCtD
Acamprosate—Pruritus—Doxorubicin—urinary bladder cancer	0.000306	0.000307	CcSEcCtD
Acamprosate—Vomiting—Epirubicin—urinary bladder cancer	0.000297	0.000298	CcSEcCtD
Acamprosate—Nausea—Methotrexate—urinary bladder cancer	0.000296	0.000298	CcSEcCtD
Acamprosate—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000296	0.000297	CcSEcCtD
Acamprosate—Rash—Epirubicin—urinary bladder cancer	0.000294	0.000296	CcSEcCtD
Acamprosate—Dermatitis—Epirubicin—urinary bladder cancer	0.000294	0.000296	CcSEcCtD
Acamprosate—Headache—Epirubicin—urinary bladder cancer	0.000293	0.000294	CcSEcCtD
Acamprosate—Dizziness—Doxorubicin—urinary bladder cancer	0.000286	0.000287	CcSEcCtD
Acamprosate—Nausea—Epirubicin—urinary bladder cancer	0.000277	0.000279	CcSEcCtD
Acamprosate—Vomiting—Doxorubicin—urinary bladder cancer	0.000275	0.000276	CcSEcCtD
Acamprosate—Rash—Doxorubicin—urinary bladder cancer	0.000272	0.000274	CcSEcCtD
Acamprosate—Dermatitis—Doxorubicin—urinary bladder cancer	0.000272	0.000274	CcSEcCtD
Acamprosate—Headache—Doxorubicin—urinary bladder cancer	0.000271	0.000272	CcSEcCtD
Acamprosate—Nausea—Doxorubicin—urinary bladder cancer	0.000257	0.000258	CcSEcCtD
Acamprosate—SLC36A1—lymph node—urinary bladder cancer	0.000234	0.0478	CbGeAlD
Acamprosate—GABRB3—female reproductive system—urinary bladder cancer	0.000195	0.0397	CbGeAlD
